Fujitsu launched a new cloud-based platform that allows users to securely collect and leverage health-related data.
The new platform automatically converts medical data from medical institutions' electronic medical records to conform with the next-generation standards framework HL7 FHIR,
Consenting patients can securely store personal health information such as vital data, step counts, and calorie consumption.
These are converted into non-personally identifiable information on the platform, which supports medical institutions and pharmaceutical companies in performing data analysis and R&D activities.
The new offering represents Fujitsu’s ongoing efforts to promote digital transformation in the medical field and contribute to the creation of a healthy society.
Fujitsu will also use the platform to develop a data portability service that enables patients to view their medical data on their smartphones and allows medical institutions to conduct a highly accurate analysis of shared medical data on the platform.
Fujitsu said it aims to leverage this platform to realize an AI and IoT-based preventive healthcare system and cooperate with various medical institutions and companies to realize a digital health ecosystem.


Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
S&P 500 Rises as AI Stocks and Small Caps Rally on Strong Earnings Outlook
Starmer’s China Visit Highlights Western Balancing Act Amid U.S.-China Rivalry
EU Recovery Fund Faces Bottlenecks Despite Driving Digital and Green Projects
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
South Korea Factory Activity Hits 18-Month High as Export Demand Surges
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Philippines Manufacturing PMI Hits Nine-Month High Despite Weak Confidence Outlook
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban 



